Friday, 22 October 2021

 

 

LATEST NEWS Make All Efforts For Instilling Confidence Of General Public In Law And Order Machinery- Cm To Punjab Police Youth To Be Deciding Factor In Vidhan Sabha Polls : Charanjit Singh Channi Massive protest against Cong MLA Joginderpal at Pathankot Police Commemoration Day observed at DPL Pulwama Intense Dengue control measures afoot Punjab Government To Come Up With A Roadmap To Revamp Education System : Pargat Singh The public knows who did corruption and who went to the court for the same : Vinod Thakur Central University of Punjab organized an Invited lecture on “Universal Human Values” Raja Warring's report card does not include any action against political transport mafia : Dinesh Chadha Tamannah Bhatia among top 10 most influential social media stars in south Being Punjabi an advantage in portraying a 'Sardar' : Pawan Malhotra Debina Bonnerjee's prosthetics for 'Shubho Bijoya' will leave you in shock Government recognizes Purzgars as vital pillar in Shawl Industry Police Martyrs Day observed at DPL Ganderbal, Pulwama Director Agriculture Kashmir inaugurates sale of Vegetable seedlings at Kitchen Garden, Lal Mandi Snow forecast : DC Bandipora reviews winter preparedness Disst. Adm. Kupwara organizes 4 block diwas programmes at Hayhama, Langate, Kalaroos, Tad Sonamarg to be promoted as all season tourist destination : Pandurang Kondbara Pole Charanjit Singh Channi Reviews Preparedness For Progressive Punjab Investors Summit We Should Fight Anti-National Forces Jointly : Gurpreet Singh Bhullar Commissionerate Police Give Rousing Welcome To Motorcycle Rally On Its Arrival At Jalandhar To Mark National Unity Day

 

Covid oral pill could be ready by year-end : Pfizer CEO

Coronavirus, COVID 19, Novel Coronavirus, Covaxin, Covishield, Covid-19 Vaccine, COVID-19 Vaccination, COVID Vaccination, Coronavirus Vaccine, Oxygen, #OxygenCylinders, #oxygen, Oxygen Cylinders, SARS-CoV-2, Pfizer, Albert Bourla, Covid oral pill, Food and Drug Administration, Emergency Use Authorisation

Web Admin

Web Admin

5 Dariya News

New York , 02 May 2021

US-based pharmaceutical major Pfizer's Chief Executive Officer Albert Bourla said that the company's Covid-19 oral antiviral pill, which is in early-stage trials, could be ready by the end of the year, the media reported.According to CNBC, the company, which developed the first authorised Covid-19 vaccine in the US with German drugmaker BioNTech, began an early-stage clinical trial for testing a new antiviral therapy for Covid-19 in March.The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells."If clinical trials go well and the Food and Drug Administration (FDA) approves it, the drug could be distributed across the US by the end of the year," Bourla told CNBC.Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C, the report said.Last month, the pharmaceutical giant asked the US Food and Drug Administration (FDA) to expand the Emergency Use Authorisation (EUA) for its Covid-19 vaccine to include children ages 12 to 15.The request to expand emergency use comes just days after Pfizer released data demonstrating its vaccine was 100 per cent effective and well-tolerated by the younger group.Pfizer is also working on its vaccine for 6-month to 11-year-old children.A recent study, published in the journal Science, showed that a single dose of Pfizer-BioNTech vaccines against Covid may boost immunity against the Covid-19 variants, only in people who were previously infected with the deadly virus.In people who have not previously been infected and have so far only received one dose of vaccine, the immune response to variants of concern may be insufficient, the study indicated.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , Coronavirus Vaccine , Oxygen , #OxygenCylinders , #oxygen , Oxygen Cylinders , SARS-CoV-2 , Pfizer , Albert Bourla , Covid oral pill , Food and Drug Administration , Emergency Use Authorisation

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD